Context Capital Management »

Ptc Therapeutics shares owned by Context Capital Management

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by Context Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $21B 22M 918.80
2023-09-30 $7.2M 9.0k 795.44